COVID 19 Infection Risk in Multiple Sclerosis Patients
May 22, 2020
In December 2019, a novel corona virus. SARS-COV2 was identified in China. It rapidly spread around the world and was officially declared a pandemic by World Health Organization in early March 2020.New York City quickly became an epicenter of infection. Routine medical care and daily life dramatically changed to prevent spread of SARS-COV2.At the Weill Cornell MS center, we have continued care through urgent in-person visits if needed and virtual visits and infusion treatments in patients...
Patient Safety Measures as we re-expand patient care at the Weill Cornell Multiple Sclerosis Center during the COVID19 Pandemic
May 15, 2020
Patient safety is utmost on our mind as we continue to provide the best care we can for our patients at the MS Center. We have put serious thought into this and have a meticulous plan to maintain a sterile environment and put in place practices that will decrease exposure risk for patients and staff The following is a list of procedures and practices that will be observed 1. Prior to in-person visits, patients will be screened for symptoms suspicious for COVID19 infection, and patients...
Important Information about patient visits to the MS Center in light of COVID 19 Risk
March 12, 2020
Update on the coronavirus SARS-CoV-2 and the respiratory illness COVID 19: Incubation period and rationale for 14 days of Quarantine
